The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Saxagliptin and Metformin
saxagliptin and metformin · SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 · Tablet, Film Coated, Extended Release · Oral · Mylan Pharmaceuticals Inc.
NDC 00378-8175-93 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$418.65
Reported to Texas DSHS · 2026 annual filing · Mylan Pharmaceuticals Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$12,009
22 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.0%chance of a new FDA shortage posting for saxagliptin and metformin (oral solid) in the next 90 days
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA205981
- TE code
- AB
- Approval date
- Jul 31, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of saxagliptin and metformin (Tablet, Film Coated, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 5 mg/1; METFORMIN HYDROCHLORIDE 500 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 2.5 mg/1; METFORMIN HYDROCHLORIDE 1000 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 500 mg/1; METFORMIN HYDROCHLORIDE 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 1000 mg/1; METFORMIN HYDROCHLORIDE 2.5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Mylan Pharmaceuticals Inc. | SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 1000 mg/1; METFORMIN HYDROCHLORIDE 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Mylan Pharmaceuticals Inc. | METFORMIN HYDROCHLORIDE 500 mg/1; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Mylan Pharmaceuticals Inc. | METFORMIN HYDROCHLORIDE 1000 mg/1; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Mylan Pharmaceuticals Inc. | METFORMIN HYDROCHLORIDE 1000 mg/1; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE 2.5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Saxagliptin and Metformin — NDC 00378-8175-93," retrieved September 3, 2026, https://drugdashboards.com/drug/00378817593.
Free to cite with attribution — see how the data is put together.